BCL6 and B-cell non-Hodgkin lymphoma: While BCL6 expression is associated with the EBV latent antigens EBNA2 and LMP1, conflicting results have not provided a comprehensive explanation or detailed mechanism for EBV-mediated BCL6 degradation in B-cell lymphoma (28, –, 30).